Zdrowie i gospodarka · 11/09/2026

FDA Classifies Cardiovascular Machine Learning-Based Notification Software as Class II Device

The FDA has classified the cardiovascular machine learning-based notification software as a Class II device, which will provide a reasonable assurance of its safety and effectiveness, and reduce regulatory burdens, ultimately enhancing patients' access to innovative devices.